Copyright
©2010 Baishideng.
World J Gastroenterol. Feb 14, 2010; 16(6): 673-682
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.673
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.673
Table 1 Progression-free and overall survival analyses from the ECOG 6201 trial[11]
| Parameter | PFS | OS | ||
| Median (mo) | Log-rank P | Median (mo) | Log-rank P | |
| All eligible patients (n = 824) | 2.9 | 5.6 | ||
| Gem (n = 275) | 2.6 | 4.9 | ||
| FDR Gem (n = 277) | 3.5 | 0.09 | 6.2 | 0.15 |
| GemOx (n = 272) | 2.7 | 5.7 | ||
- Citation: Bayraktar S, Bayraktar UD, Rocha-Lima CM. Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. World J Gastroenterol 2010; 16(6): 673-682
- URL: https://www.wjgnet.com/1007-9327/full/v16/i6/673.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i6.673